Promising Advances in Treating Renal Medullary Carcinoma
Unlike other types of kidney cancer, RMC poses a significant challenge with less than 5 percent of patients surviving beyond three years using standard treatments. However, recent research offers new hope.
What Should Sickle Cell Patients Know About Lab Test Ranges?
How are laboratory reference ranges determined as it relates to sickle cell? Hear from hematology nurse practitioner Maya Bloomberg.
How Do Sickle Cell Disease and APOL1 Impact FSGS?
Sickle cell disease is listed in some research as a cause of focal segmental glomerulosclerosis (FSGS), and APOL1 kidney disease treatments are under research. Here’s a look at FSGS and the APOL1 gene and how they relate to SCD and other conditions.
Sickle Cell Disease vs Sickle Cell Trait, What’s the Difference?
Dr. Seethal Jacob explains how the two conditions differ, when symptoms can manifest, and subtypes of the blood disorder.
Ensuring Pneumococcal Immunity in Sickle Cell Disease Children
The genetic condition of sickle cell disease (SCD) results when sickle cell genes are inherited from each parent. We connected with Dr. Seethal Jacob about a study on maintaining an immune response against pneumococcal bacteria in children with SCD.
High-Intensity Exercise and Renal Medullary Carcinoma in Those With Sickle Cell Trait
As the most commonly occurring blood disorder in the world, sickle cell trait primarily impacts those in the BIPOC community with African ancestry. We connected with Dr. Pavlos Msaouel about a study on high-intensity exercise in those with sickle cell trait.